20 集

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

DIA: Driving Insights to Action Unknown

    • 科學

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

    DIA: A Place Where You Can Make a Difference

    DIA: A Place Where You Can Make a Difference

    Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2024.

    • 1 分鐘
    Autumn’s Leukemia Story: Regimens, Recovery, and Realizations

    Autumn’s Leukemia Story: Regimens, Recovery, and Realizations

    A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a new chapter not only in Autumn’s life but in the life of her entire family: Autumn had leukemia. In this interview, Autumn shares the story of her treatment and recovery as a girl who had not yet turned 11. Her experience was also captured in a documentary. When asked to share her advice to healthcare professionals and researchers as a pediatric oncology patient, Autumn explained: “Every patient is a different case, has a different body, and knows about their body. No matter how amazing you are at the job, keep in mind what children have to say instead of what you already know.”

    • 19 分鐘
    Retiring TGA Head Maps Australia’s Post-Pandemic Future

    Retiring TGA Head Maps Australia’s Post-Pandemic Future

    In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulation Group and head of the Therapeutic Goods Administration in Australia. “What's really changed and what will persist after COVID? First, I think regulators have become a bit more comfortable in dealing with uncertainty. Uncertainty is the biggest challenge rather than benefit-risk,” he explains. “International regulatory collaboration became the basis of working together on these new products: We exchanged information on policies, on how the clinical data was developing, on the real-world performance of these drugs and vaccines, and on safety and post-approval requirements. These are going to persist.”

    • 18 分鐘
    Patient Engagement: Evolution of Who Knows What, Part 2

    Patient Engagement: Evolution of Who Knows What, Part 2

    In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in the future of patient engagement in clinical research and care with DIA GAM 2023 Patient Engagement track chair Pujita Vaidya. “This advent and acceleration of artificial intelligence (which should be augmented intelligence) and digital biomarkers should not replace the physician-patient relationship but enhance it,” Stacy explains. “Lastly: If you want sustainable patient insights, don't only ask a patient, but invest in and hire patients as internal subject matter experts and full-time employees of your organization.” Listen to part 1.

    • 14 分鐘
    Patient Engagement: Evolution of Who Knows What, Part 1

    Patient Engagement: Evolution of Who Knows What, Part 1

    DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clinical research and care with cancer survivors and “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel). “Many people were trained for generations to think of patients as poor people who just don't understand how to save their own lives. I'm here to tell you, we are not only eager to help but we're tired of being treated as crash test dummies,” Dave says. “Engagement doesn't just mean invite me into your process. It also means listen to me as a thinking, intelligent person who might have some ideas that you haven't thought of.”

    • 18 分鐘
    Australian Clinical Trials Alliance Part 2 – Future Projections

    Australian Clinical Trials Alliance Part 2 – Future Projections

    “Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance board chair. “But we can see big improvements in health outcomes, combined with substantially better financial performance of the healthcare system, if the healthcare system has the dual role of treating patients as well as generating evidence about the most effective treatment options to guide that care.”

    • 14 分鐘

關於科學的熱門 Podcast

老高與小茉 Mr & Mrs Gao
老高與小茉 Mr & Mrs Gao
Hidden Brain
Hidden Brain, Shankar Vedantam
Discovery
BBC World Service
Kurzgesagt - In a Nutshell
Kurzgesagt
Science, Quickly
Scientific American
Science Vs
Spotify Studios